Ethnicity differences in plasma apoC-III levels between African American and Caucasian youths

World Journal of Pediatrics

Volumn 7, Issue 2, 2011, Pages 136-142

  Lee, Ji Young ^a   Hong, Hye Ryun ^b   Kang, Hyun Sik ^b  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

adiposity; ethnicity; lipoprotein lipids; pediatrics; risk factors

Indexed keywords

APOLIPOPROTEIN C3; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AFRICAN AMERICAN; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; DUAL ENERGY X RAY ABSORPTIOMETRY; ETHNIC DIFFERENCE; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADIPOSE TISSUE; ADOLESCENT; AFRICAN AMERICANS; APOLIPOPROTEIN C-III; APOLIPOPROTEINS E; BODY COMPOSITION; BODY MASS INDEX; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; TRIGLYCERIDES;

EID: 79956367676     PISSN: 17088569     EISSN: 18670687     Source Type: Journal    
DOI: 10.1007/s12519-011-0266-8     Document Type: Article

References (30)

1. I. Lemieux A. Pascot C. Couillard B. Lamarche A. Tchernof N. Alméras, et al. 2000 Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 102 179 184 10889128 1:STN:280: DC%2BD3czkvFeqsQ%3D%3D (Pubitemid 30451774)
2. F.L. Game A.F. Jones 2001 Coronary heart disease risk assessment in diabetes mellitus-a comparison of PROCAM and Framingham risk assessment functions Diabetic Med 18 355 359 11472444 10.1046/j.1464-5491.2001.00438.x 1:STN:280:DC%2BD3MvisFWktw%3D%3D (Pubitemid 32679382)
3. M.A. Pereira P.J. Schreiner J.S. Pankow R.R. Williams M. Higgins M.A. Province, et al. 2000 The Family Risk Score for coronary heart disease: associations with lipids, lipoproteins, and body habitus in a middle-aged bi-racial cohort: The ARIC study Ann Epidemiol 10 239 245 10917717 10.1016/S1047-2797(99)00056-3 1:STN:280:DC%2BD3czntVWitQ%3D%3D (Pubitemid 30330957)
4. A.E. Sumner 2009 Ethnic differences in triglyceride levels and high-density lipoprotein lead to underdiagnosis of the metabolic syndrome in black children and adults J Pediatr 155 Suppl7 e7 e11 19732569
5. S.F. Burns S. Lee S.A. Arslanian 2009 In vivo insulin sensitivity and lipoprotein particle size and concentration in black and white children Diabetes Care 32 2087 2093 19675203 10.2337/dc09-0380 1:CAS:528:DC%2BD1MXhsVOgtrbJ
6. S.M. Haffner R. D'Agostino Jr D. Goff B. Howard A. Festa M.F. Saad, et al. 1999 LDL size in African Americans, Hispanics, and non-Hispanic whites: the insulin resistance atherosclerosis study Arterioscler Thromb Vasc Biol 19 2234 2240 10479667 1:CAS:528:DyaK1MXmtFOrtLo%3D (Pubitemid 29422257)
7. F. Bacha R. Saad N. Gungor J. Janosky S.A. Arslanian 2003 Obesity, regional fat distribution, and syndrome X in obese black versus white adolescents: race differential in diabetogenic and atherogenic risk factors J Clin Endocrinol Metab 88 2534 2540 12788850 10.1210/jc.2002-021267 1:CAS:528:DC%2BD3sXkslCkurY%3D (Pubitemid 36724419)
8. D.S. Freedman B.A. Bowman J.D. Otvos S.R. Srinivasan G.S. Berenson 2000 Levels and correlates of LDL and VLDL particle sizes among children: the Bogalusa Heart Study Atherosclerosis 152 441 449 10998473 10.1016/S0021-9150(99) 00495-5 1:CAS:528:DC%2BD3cXms1WktLg%3D
9. Breslow JL. Familial disorders of high density lipoprotein metabolism. In: Scriver CR, Beaudet Al, Sly WS, Valle D, eds. The metabolic basis of inherited disease. New York: McGraw-Hill, 1995: 1251-1266.
10. H.N. Hodis W.J. Mack S.P. Azen P. Alaupovic J.M. Pogoda LaBree, et al. 1994 Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin Circulation 90 42 49 8026027 1:STN:280:DyaK2c3pvVWrsQ%3D%3D
11. N. Gervaise M.A. Garrigue G. Lasfargues P. Lecomte 2000 Triglycerides, apo C3 and Lp B:C3 and cardiovascular risk in type II diabetes Diabetologia 43 703 708 10907114 10.1007/s001250051366 1:CAS:528:DC%2BD3cXjsFKisr8%3D (Pubitemid 30409144)
12. L. Tiret C. Gerdes M.J. Murphy J. Dallongeville V. Nicaud D.S. O'Reilly, et al. 2000 Postprandial response to a fat tolerance test in young adults with a paternal history of premature coronary heart disease-the EARS II study Eur J Clin Invest 30 578 585 10886297 10.1046/j.1365-2362.2000.00674.x 1:STN:280:DC%2BD3cvjs1aksw%3D%3D (Pubitemid 30453657)
13. DCCT Research Group. DCCT manual of operations (Publ. No. 93-183382). Springfield, VA: National Technical Information Service, 1993.
14. D.R. Matthews J.P. Hosker A.S. Rudenski B.A. Naylor D.F. Treacher R. Turner 1985 Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 412 419 3899825 10.1007/BF00280883 1:CAS:528:DyaL2MXlslKnu7k%3D (Pubitemid 15018832)
15. N.A. Le W. Innis-Whitehouse X. Li R. Bakker-Arkema D. Black W.V. Brown 2000 Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: effect of triglyceride reduction with atorvastatin Metabolism 49 167 177 10690940 10.1016/S0026-0495(00)91169-7 1:CAS:528:DC%2BD3cXht1yhtrk%3D (Pubitemid 30090879)
16. D.B. Allison F. Paultre M.I. Goran E.T. Poehlman S.B. Heymsfield 1995 Statistical considerations regarding the use of ratios to adjust data Int J Obes Relat Metab Disord 19 644 652 8574275 1:STN:280:DyaK28%2FnvFWnsA%3D%3D
17. C.S. Wang W.J. McConathy H.U. Kloer P. Alaupovic 1985 Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III J Clin Invest 75 384 390 3973011 10.1172/JCI111711 1:CAS:528:DyaL2MXht12ku78%3D (Pubitemid 15143476)
18. K. Aalto-Setälä E.A. Fisher X. Chen T. Chajek-Shaul T. Hayek R. Zechner, et al. 1992 Mechanism of hypertriglyceridemia in human apolipoprotein (apo) C-III transgenic mice Diminished very low density lipoprotein fractional catabolic rate associated with increased apo C-III and reduced apo E on the particles. J Clin Invest 90 1889 1900
19. C. Zheng C. Khoo K. Ikewaki F.M. Sacks 2007 Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractions J Lipids Res 48 1190 1203 10.1194/jlr.P600011- JLR200 1:CAS:528:DC%2BD2sXls1ejur0%3D (Pubitemid 46708686)
20. O. Olivieri A. Bassi C. Stranieri E. Trabetti N. Martinelli F. Pizzolo, et al. 2003 Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease J Lipid Res 44 2374 2381 14563827 10.1194/jlr.M300253-JLR200 1:CAS:528:DC%2BD2cXmsVyltA%3D%3D (Pubitemid 38082496)
21. J.S. Cohn B.W. Patterson K.D. Uffelman J. Davignon G. Steiner 2004 Rate of production of plasma and very-low density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity J Clin Endocrinol Metab 89 3949 3955 15292332 10.1210/jc.2003-032056 1:CAS:528:DC%2BD2cXmslKmurg%3D (Pubitemid 39071498)
22. H. Florez A. Mendez P. Casanova-Romero C. Larreal-Urdaneta S. Castillo-Florez D. Lee, et al. 2006 Increased apolipoprotein C-III levels associated with insulin resistance contribute to dyslipidemia in normoglycemic and diabetic subjects from a triethnic population Atherosclerosis 188 134 141 16298371 10.1016/j.atherosclerosis.2005.10.013 1:CAS:528:DC%2BD28XotV2nsbc%3D (Pubitemid 44142528)
23. J.P. Després C. Couillard J. Gagnon J. Bergeron A.S. Leon D.C. Rao, et al. 2000 Visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) Family Study Arterioscler Thromb Vasc Biol 20 1932 1938 10938014 (Pubitemid 30644643)
24. R.W. Mahley S.C. Rall Jr. 2000 Apolipoprotein E: far more than a lipid transport protein Annu Rev Genomics Hum Genet 1 507 537 11701639 10.1146/annurev.genom.1.1.507 1:CAS:528:DC%2BD3cXnsVarsrY%3D
25. V.S. Kashyap S. Santamarina-Fojo D.R. Brown C.L. Parrott D. Applebaum-Bowden S. Meyn, et al. 1995 Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors J Clin Invest 96 1612 1620 7657831 10.1172/JCI118200 1:CAS:528:DyaK2MXnvVGqu74%3D
26. E. Sehayek S. Eisenberg 1991 Mechanisms of inhibition of apolipoprotein C on apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway J Biol Chem 266 18259 18267 1917954 1:CAS:528:DyaK3MXltlamsLw%3D (Pubitemid 21908074)
27. M. Chen J.L. Breslow W. Li T. Leff 1994 Transcriptional regulation of the apoC-III gene by insulin in diabetic mice: correlation with changes in plasma triglyceride levels J Lipid Res 35 1918 1924 7868970 1:CAS:528: DyaK2cXmvFehu7g%3D (Pubitemid 24353064)
28. M. Castro Cabezas T.W. de Bruin H.W. de Valk C.C. Shoulders H. Jansen D. Willem Erkelens 1993 Impaired fatty acid metabolism in familial combined hyperlipidemia A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance. J Clin Invest 92 160 168 1:STN:280:DyaK3szhsFKgug%3D%3D
29. D.M. Waterworth P.J. Talmud S.E. Humphries P.D. Wicks G.A. Sagnella P. Strazzullo, et al. 2001 Variable effects of the apoC3-482C>T variant on insulin, glucose and triglyceride concentrations in different ethnic groups Diabetologia 44 245 248 11270684 10.1007/s001250051607 1:CAS:528: DC%2BD3MXntlSktQ%3D%3D (Pubitemid 32156211)
30. R.E. Peacock A. Temple V. Gudnason M. Rosseneu S.E. Humphries 1997 Variation at the lipoprotein lipase and apolipoprotein AICIII gene loci are associated with fasting lipids and lipoprotein traits in a population sample from Iceland: Interaction between genotype, gender, and smoking status Genet Epidemiol 14 265 282 9181356 10.1002/(SICI)1098-2272(1997)14:3<265::AID- GEPI5>3.0.CO;2-4 1:STN:280:DyaK2szisFejsQ%3D%3D (Pubitemid 27240933)